Fundraising Fox

Qureator

San Diego, US · Delaware corporation

qureator.com

Qureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.

BiotechDeep Tech

Founders & leadership

KBKyusuk Baek
Kyusuk BaekFounder
PPPaul Park
Paul ParkConsulting Chief Business Officer
NL
Noo Li JeonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6.7M disclosed across 1 round · 2025

$6.7MraisedMar 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kyusuk BaekExecutive Officer, Director
  • Noo Li JeonDirector
Offering amount
$6.9M
Amount sold
$6.7M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Qureator for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Qureator do?
Qureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
Who founded Qureator?
Qureator was founded by Kyusuk Baek.
How much funding has Qureator raised?
Qureator has disclosed $6.7M raised across 1 round.
Where is Qureator headquartered?
Qureator is headquartered in San Diego, US.